Colombier Acquisition Corp. III (CLBR)

Colombier Acquisition Corp. III is a special purpose acquisition company, commonly known as a SPAC or blank-check company. These entities raise capital from public investors with a single, explicit purpose: to find and merge with an operating business within a set timeframe, typically two years. The investors and sponsor agree upfront that the SPAC itself will not operate a traditional business. Instead, the capital sits in trust while management hunts for an acquisition target. This structure offers private companies a faster path to public markets than a traditional IPO, and it gives retail investors early exposure to private ventures.

How SPACs work

A SPAC raises money through an IPO but commits the capital to a trust that cannot be deployed except for a merger or acquisition. From IPO date, sponsors have roughly 24 months to announce and complete a deal. If no merger closes before the deadline, the SPAC liquidates — capital is returned to shareholders and the company ceases. That hard deadline creates pressure: sponsors earn “promote” equity (shares at nominal price) only if a deal closes, incentivizing them to complete a transaction rather than necessarily wait for the right one.

When a SPAC merges with a target, the private company becomes public and the SPAC’s shell dissolves. Early SPAC investors face dilution from sponsor warrants and redemptions (where shareholders withdraw capital rather than accept a deal). The structure works well when a quality target is found at fair value; it fails when sponsors rush into mediocre deals just to avoid deadline misses. A 2022 study found that many SPAC-acquired companies underperformed public markets post-merger, particularly those from the 2020–2021 boom when hundreds of SPACs pursued trendy sectors like electric vehicles and space.

The investment risks

SPAC sponsors must disclose their conflicts and past deal experience, yet aligned incentives remain: they profit only on close, not on quality of outcome. Regulatory scrutiny has increased, particularly around sponsor compensation and forward-looking statements. Yet the core tension persists: a SPAC is a capital pool, not a business, and shareholders are betting on the judgment and integrity of the sponsor team rather than on cash flows or products.

For investors evaluating a SPAC like Colombier, the due-diligence checklist is essentially the acquisition checklist: Is the target defensible? Can it scale? Are terms fair? What conflicts influenced the deal? And will the newly public company achieve promised growth or fall short post-merger, as many have done?